Keros Therapeutics Inc

Insightful insider buying by Keros Therapeutics’ CEO signals potential upcoming clinical or partnership milestones that could boost shareholder value amid volatile biotech markets.

Insider sales at Keros Therapeutics are routine sell‑to‑cover moves for tax‑withholding, not a signal of panic—investors should watch clinical milestones and funding rounds for real impact.